OBIO
Orchestra BioMed Holdings, Inc.$7.17-0.08 (-1.10%)Prev Close$7.25·MCap$570.6M·P/E—·Vol479.3K·Yield—
▲
Buys (12M)
13
$6.49M
▼
Sells (12M)
15
$958.2K
◆
Net Activity
Net Buyer
$5.53M
●
Active Insiders
13
last 12 mo
Over the past 12 months, insider activity at Orchestra BioMed Holdings, Inc. (OBIO) has been dominated by buying, with 13 insider purchases totaling $6.49M and 15 insider sales totaling $958.2K. The most recent insider transaction was by RTW INVESTMENTS, LP (10 percent owner), who purchased $6.00M worth of shares on Nov 12, 2026. Orchestra BioMed Holdings, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $570.6M.
OBIO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | RTW INVESTMENTS, LP | 10 percent owner | Buy | 1,200,000 | $5.00 | $6.00M2.0% OS | 10,756,063 |
| Nov 9, 2026 | Hochman David P | director, officer: See Remarks | Buy | 5,000 | $5.00 | $25.0K | 437,916 |
| Nov 9, 2026 | Taylor Andrew Lawrence | officer: Chief Financial Officer | Buy | 1,000 | $5.00 | $5.0K | 590,989 |
| Nov 9, 2026 | Pacitti David | director | Buy | 20,000 | $5.00 | $100.0K | 74,750+37% |
| Nov 9, 2026 | Fain Eric S | director | Buy | 20,000 | $5.00 | $100.0K | 119,630 |
| Nov 3, 2026 | Sherman Darren | director, officer: See Remarks | Sell | 15,000 | $5.74 | $86.1K | 1,104,402 |
| Oct 2, 2026 | Sherman Darren | director, officer: See Remarks | Sell | 15,000 | $6.36 | $95.4K | 1,119,402 |
| Sep 8, 2026 | Hochman David P | director, officer: See Remarks | Buy | 10,000 | $4.79 | $47.9K | 1,070,746 |
| Sep 2, 2026 | Sherman Darren | director, officer: See Remarks | Sell | 15,000 | $4.94 | $74.1K | 1,134,402 |
| Aug 28, 2026 | Sherman Darren | director, officer: See Remarks | Buy | 2,000 | $5.33 | $10.7K | 2,000 |
| Aug 4, 2026 | Sherman Darren | director, officer: See Remarks | Sell | 15,000 | $4.09 | $61.4K | 1,154,327 |
| Jul 2, 2026 | Sherman Darren | director, officer: See Remarks | Sell | 15,000 | $4.27 | $64.0K | 1,169,327 |
| Jun 2, 2026 | Sherman Darren | director, officer: See Remarks | Sell | 15,000 | $3.87 | $58.0K | 1,184,327 |
| Jun 2, 2026 | Hochman David P | director, officer: See Remarks | Buy | 5,000 | $3.83 | $19.1K | 1,064,029 |
| May 20, 2026 | Aryeh Jason | director | Buy | 665 | $3.75 | $2.5K | 118,118 |
| May 19, 2026 | Aryeh Jason | director | Buy | 8,971 | $3.90 | $35.0K | 117,453 |
| May 19, 2026 | Hochman David P | director, officer: See Remarks | Buy | 5,000 | $3.77 | $18.9K | 1,059,029 |
| May 18, 2026 | Fain Eric S | director | Buy | 20,000 | $4.13 | $82.6K | 91,709+28% |
| Apr 29, 2026 | RTW INVESTMENTS, LP | 10 percent owner | Sell | 32 | $4.13 | $132.16 | 9,556,063 |
| Mar 16, 2026 | Hochman David P | director, officer: See Remarks | Buy | 10,000 | $4.29 | $42.9K | 1,086,467 |
| Feb 5, 2026 | Cleary Chris | Director | Sell | 676 | $3.71 | $2.5K | 0 |
| Jan 2, 2026 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 3,452 | $4.31 | $14.9K | 0 |
| Jan 2, 2026 | Aiello Joshua | Principal Accounting Officer | Sell | 241 | $4.31 | $1.0K | 0 |
| Jan 2, 2026 | Sherman Darren | See Remarks | Sell | 5,588 | $4.31 | $24.1K | 0 |
| Dec 10, 2025 | Hochman David P | See Remarks | Sell | 43,638 | $4.67 | $203.8K | 0 |
| Dec 10, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 8,670 | $4.67 | $40.5K | 0 |
| Nov 25, 2025 | Sherman Darren | See Remarks | Sell | 40,340 | $5.35 | $215.8K | 0 |
| Nov 25, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 3,071 | $5.35 | $16.4K | 0 |
| Nov 14, 2025 | Hochman David P | See Remarks | Buy | 5,000 | $4.07 | $20.4K | 0 |
| Nov 13, 2025 | Hochman David P | See Remarks | Sell | 3,283 | $4.18 | $13.7K | 0 |
| Sep 19, 2025 | Aryeh Jason | Director | Buy | 1,000 | $2.45 | $2.5K | 0 |
| Sep 17, 2025 | Aiello Joshua | Principal Accounting Officer | Sell | 203 | $2.46 | $499.38 | 0 |
| Sep 17, 2025 | Hochman David P | See Remarks | Sell | 43,638 | $2.46 | $107.3K | 0 |
| Sep 17, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 16,102 | $2.46 | $39.6K | 0 |
| Sep 3, 2025 | Sherman Darren | See Remarks | Sell | 40,340 | $2.72 | $109.7K | 0 |
| Aug 25, 2025 | Fain Eric S | Director | Buy | 5,760 | $2.61 | $15.0K | 0 |
| Aug 25, 2025 | Sherman Darren | See Remarks | Buy | 3,000 | $2.62 | $7.9K | 0 |
| Aug 25, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Buy | 2,000 | $2.55 | $5.1K | 0 |
| Aug 21, 2025 | Hochman David P | See Remarks | Buy | 6,000 | $2.49 | $14.9K | 0 |
| Aug 4, 2025 | Hochman David P | See Remarks | Buy | 20,000 | $2.75 | $55.0K | 0 |
| Jun 26, 2025 | Fain Eric S | Director | Sell | 2,683 | $3.05 | $8.2K | 0 |
| Jun 18, 2025 | Aiello Joshua | Principal Accounting Officer | Sell | 393 | $2.99 | $1.2K | 0 |
| Jun 11, 2025 | Hochman David P | See Remarks | Sell | 39,709 | $3.14 | $124.7K | 0 |
| Jun 11, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 28,172 | $3.14 | $88.5K | 0 |
| May 28, 2025 | Sherman Darren | See Remarks | Sell | 45,843 | $2.95 | $135.2K | 0 |
| Mar 26, 2025 | Aiello Joshua | Principal Accounting Officer | Sell | 278 | $4.38 | $1.2K | 0 |
| Mar 7, 2025 | Hochman David P | See Remarks | Sell | 80,080 | $4.23 | $338.7K | 0 |
| Dec 26, 2024 | Hochman David P | See Remarks | Buy | 4,000 | $4.66 | $18.6K | 579,498 |
| Dec 20, 2024 | Taylor Andrew Lawrence | Chief Financial Officer | Buy | 1,000 | $4.83 | $4.8K | 344,960 |
| Dec 19, 2024 | Hochman David P | See Remarks | Buy | 5,000 | $4.91 | $24.6K | 575,498 |
Showing 1–50 of 57
1 / 2
OBIO Insider Buying Activity
The following table shows recent insider purchases of Orchestra BioMed Holdings, Inc. (OBIO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | RTW INVESTMENTS, LP | 10 percent owner | Buy | 1,200,000 | $5.00 | $6.00M2.0% OS | 10,756,063 |
| Nov 9, 2026 | Hochman David P | director, officer: See Remarks | Buy | 5,000 | $5.00 | $25.0K | 437,916 |
| Nov 9, 2026 | Taylor Andrew Lawrence | officer: Chief Financial Officer | Buy | 1,000 | $5.00 | $5.0K | 590,989 |
| Nov 9, 2026 | Pacitti David | director | Buy | 20,000 | $5.00 | $100.0K | 74,750+37% |
| Nov 9, 2026 | Fain Eric S | director | Buy | 20,000 | $5.00 | $100.0K | 119,630 |
| Sep 8, 2026 | Hochman David P | director, officer: See Remarks | Buy | 10,000 | $4.79 | $47.9K | 1,070,746 |
| Aug 28, 2026 | Sherman Darren | director, officer: See Remarks | Buy | 2,000 | $5.33 | $10.7K | 2,000 |
| Jun 2, 2026 | Hochman David P | director, officer: See Remarks | Buy | 5,000 | $3.83 | $19.1K | 1,064,029 |
| May 20, 2026 | Aryeh Jason | director | Buy | 665 | $3.75 | $2.5K | 118,118 |
| May 19, 2026 | Aryeh Jason | director | Buy | 8,971 | $3.90 | $35.0K | 117,453 |
| May 19, 2026 | Hochman David P | director, officer: See Remarks | Buy | 5,000 | $3.77 | $18.9K | 1,059,029 |
| May 18, 2026 | Fain Eric S | director | Buy | 20,000 | $4.13 | $82.6K | 91,709+28% |
| Mar 16, 2026 | Hochman David P | director, officer: See Remarks | Buy | 10,000 | $4.29 | $42.9K | 1,086,467 |
| Nov 14, 2025 | Hochman David P | See Remarks | Buy | 5,000 | $4.07 | $20.4K | 0 |
| Sep 19, 2025 | Aryeh Jason | Director | Buy | 1,000 | $2.45 | $2.5K | 0 |
| Aug 25, 2025 | Fain Eric S | Director | Buy | 5,760 | $2.61 | $15.0K | 0 |
| Aug 25, 2025 | Sherman Darren | See Remarks | Buy | 3,000 | $2.62 | $7.9K | 0 |
| Aug 25, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Buy | 2,000 | $2.55 | $5.1K | 0 |
| Aug 21, 2025 | Hochman David P | See Remarks | Buy | 6,000 | $2.49 | $14.9K | 0 |
| Aug 4, 2025 | Hochman David P | See Remarks | Buy | 20,000 | $2.75 | $55.0K | 0 |
| Dec 26, 2024 | Hochman David P | See Remarks | Buy | 4,000 | $4.66 | $18.6K | 579,498 |
| Dec 20, 2024 | Taylor Andrew Lawrence | Chief Financial Officer | Buy | 1,000 | $4.83 | $4.8K | 344,960 |
| Dec 19, 2024 | Hochman David P | See Remarks | Buy | 5,000 | $4.91 | $24.6K | 575,498 |
OBIO Insider Selling Activity
The following table shows recent insider sales of Orchestra BioMed Holdings, Inc. (OBIO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Sherman Darren | director, officer: See Remarks | Sell | 15,000 | $5.74 | $86.1K | 1,104,402 |
| Oct 2, 2026 | Sherman Darren | director, officer: See Remarks | Sell | 15,000 | $6.36 | $95.4K | 1,119,402 |
| Sep 2, 2026 | Sherman Darren | director, officer: See Remarks | Sell | 15,000 | $4.94 | $74.1K | 1,134,402 |
| Aug 4, 2026 | Sherman Darren | director, officer: See Remarks | Sell | 15,000 | $4.09 | $61.4K | 1,154,327 |
| Jul 2, 2026 | Sherman Darren | director, officer: See Remarks | Sell | 15,000 | $4.27 | $64.0K | 1,169,327 |
| Jun 2, 2026 | Sherman Darren | director, officer: See Remarks | Sell | 15,000 | $3.87 | $58.0K | 1,184,327 |
| Apr 29, 2026 | RTW INVESTMENTS, LP | 10 percent owner | Sell | 32 | $4.13 | $132.16 | 9,556,063 |
| Feb 5, 2026 | Cleary Chris | Director | Sell | 676 | $3.71 | $2.5K | 0 |
| Jan 2, 2026 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 3,452 | $4.31 | $14.9K | 0 |
| Jan 2, 2026 | Aiello Joshua | Principal Accounting Officer | Sell | 241 | $4.31 | $1.0K | 0 |
| Jan 2, 2026 | Sherman Darren | See Remarks | Sell | 5,588 | $4.31 | $24.1K | 0 |
| Dec 10, 2025 | Hochman David P | See Remarks | Sell | 43,638 | $4.67 | $203.8K | 0 |
| Dec 10, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 8,670 | $4.67 | $40.5K | 0 |
| Nov 25, 2025 | Sherman Darren | See Remarks | Sell | 40,340 | $5.35 | $215.8K | 0 |
| Nov 25, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 3,071 | $5.35 | $16.4K | 0 |
| Nov 13, 2025 | Hochman David P | See Remarks | Sell | 3,283 | $4.18 | $13.7K | 0 |
| Sep 17, 2025 | Aiello Joshua | Principal Accounting Officer | Sell | 203 | $2.46 | $499.38 | 0 |
| Sep 17, 2025 | Hochman David P | See Remarks | Sell | 43,638 | $2.46 | $107.3K | 0 |
| Sep 17, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 16,102 | $2.46 | $39.6K | 0 |
| Sep 3, 2025 | Sherman Darren | See Remarks | Sell | 40,340 | $2.72 | $109.7K | 0 |
| Jun 26, 2025 | Fain Eric S | Director | Sell | 2,683 | $3.05 | $8.2K | 0 |
| Jun 18, 2025 | Aiello Joshua | Principal Accounting Officer | Sell | 393 | $2.99 | $1.2K | 0 |
| Jun 11, 2025 | Hochman David P | See Remarks | Sell | 39,709 | $3.14 | $124.7K | 0 |
| Jun 11, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Sell | 28,172 | $3.14 | $88.5K | 0 |
| May 28, 2025 | Sherman Darren | See Remarks | Sell | 45,843 | $2.95 | $135.2K | 0 |
| Mar 26, 2025 | Aiello Joshua | Principal Accounting Officer | Sell | 278 | $4.38 | $1.2K | 0 |
| Mar 7, 2025 | Hochman David P | See Remarks | Sell | 80,080 | $4.23 | $338.7K | 0 |
OBIO Insiders
Taylor Andrew Lawrence
officer: Chief Financial Officer
Bought $14.9KSold $199.9K
8 tradesLast: Nov 9, 2026
Similar Stocks to OBIO
VRTX
Vertex Pharmaceuticals Incorporated
$535.71-0.54%
$138.69B
REGN
Regeneron Pharmaceuticals, Inc.
$951.76-0.39%
$99.23B
MRNA
Moderna, Inc.
$215.63-3.39%
$93.61B
RVMD
Revolution Medicines, Inc.
$166.91-3.13%
$39.08B
INSM
Insmed Incorporated
$123.03+1.55%
$26.58B
UTHR
United Therapeutics Corporation
$582.48-1.47%
$25.18B
INCY
Incyte Corporation
$120.36-0.50%
$24.66B
ALNY
Alnylam Pharmaceuticals, Inc.
$159.72-3.23%
$21.41B